<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>184-DISULFIRAM.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="DISULFIRAM" rxcui="3554">
<ATC code="N07BB01" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="VITAMIN K ANTAGONISTS" code="B01AA-001" /></DRUG2>
<DESCRIPTION>Increase of the effect of the vitamin K antagonist and of the risk of hemorrhage</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT>More frequent testing of the INR. Adjustment of the dosage of the vitamin K antagonist during the treatment with the disulfiram and a week after it is stopped</COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>184-DISULFIRAM.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="DISULFIRAM" rxcui="3554">
<ATC code="N07BB01" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="COCAINE" rxcui="2653">
<ATC code="S02DA02" />
</DRUG>
</DRUG2>
<DESCRIPTION>Increase of the concentrations of cocaine due to decrease of its metabolism by the disulfirame, with risk of increase of inducing torsades de pointes</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>184-DISULFIRAM.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="DISULFIRAM" rxcui="3554">
<ATC code="N07BB01" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="ISONIAZID" rxcui="6038">
<ATC code="J04AM03" />
<ATC code="J04AC01" />
<ATC code="J04AC51" />
<ATC code="J04AM02" />
<ATC code="J04AM05" />
<ATC code="J04AM06" />
<ATC code="J04AM01" />
<ATC code="J04AM04" />
</DRUG>
</DRUG2>
<DESCRIPTION>Disorders of behavior and of coordination</DESCRIPTION>
<SEVERITY>Not recommended</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>184-DISULFIRAM.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="DISULFIRAM" rxcui="3554">
<ATC code="N07BB01" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="METRONIDAZOLE" rxcui="6922">
<ATC code="A02BD08" />
<ATC code="A02BD03" />
<ATC code="A02BD02" />
<ATC code="A01AB17" />
<ATC code="D06BX01" />
<ATC code="G01AF01" />
<ATC code="J01XD01" />
<ATC code="P01AB01" />
<ATC code="A02BD01" />
</DRUG>
</DRUG2>
<DESCRIPTION>Risk of episodes of acute psychosis or confused state, reversible upon stopping the administration of the two substances together</DESCRIPTION>
<SEVERITY>Not recommended</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>184-DISULFIRAM.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="DISULFIRAM" rxcui="3554">
<ATC code="N07BB01" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="PHENYTOIN (AND, BY EXTRAPOLATION, FOSPHENYTOIN)" code="N03AB" /></DRUG2>
<DESCRIPTION>Large and rapid increase of the plasma concentrations of phenytoin with signs of toxicity (inhibition of its metabolism)</DESCRIPTION>
<SEVERITY>Not recommended</SEVERITY>
<COMMENT>If the administration of these substances together cannot be avoided, clinical monitoring and monitoring of the plasma concentrations of phenytoin during the treatment with the disulfiram and after it is stopped. </COMMENT>
</INTERACTION>
</INTERACTIONS>
